<DOC>
	<DOC>NCT01739426</DOC>
	<brief_summary>The primary objective of this study is to evaluation the success of endoscopic treatment of Zenker's diverticulum using a LigaSure device (thermal fusion of vessels) via a measure of swallowing function at 12 months post-surgery.</brief_summary>
	<brief_title>Evaluation of Endoscopic Treatment of Zenker's Diverticulum Using LigaSure</brief_title>
	<detailed_description>Our secondary objectives are: A. To evaluate short-term (pain, fever, time to start of eating) and medium-term (weight, swallowing) post-operative parameters. B. To evaluate the prevalence of post-operative complications.</detailed_description>
	<mesh_term>Diverticulum</mesh_term>
	<mesh_term>Zenker Diverticulum</mesh_term>
	<criteria>The patient must have given his/her informed and signed consent The patient must be insured or beneficiary of a health insurance plan The patient is available for 12 months of followup The patient has a Zenkers diverticulum as confirmed by a pharyngooesophagean transit test, regardless of van Overbeek classification The patient is participating in another study The patient is in an exclusion period determined by a previous study The patient is under judicial protection, under tutorship or curatorship The patient (or his/her personoftrust) refuses to sign the consent It is impossible to correctly inform the patient The patient does not read french The patient is pregnant The patient is breastfeeding The patients has a contraindication for a treatment necessary for this study, or for general anesthesia The patent has a history of complications related to hemostasis The preoperative checkup indicates potential for hemostasis related problems</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>LigaSure V (TM)</keyword>
</DOC>